Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.

Article  PubMed  Google Scholar 

Culig Z. Targeting the androgen receptor in prostate cancer. Expert Opin Pharmacother. 2014;15:1427–37.

Article  PubMed  CAS  Google Scholar 

Beltran H, Hruszkewycz A, Scher HI, Hildesheim J, Isaacs J, Yu EY, et al. The role of lineage plasticity in prostate cancer therapy resistance. Clin Cancer Res. 2019;25:6916–24.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell. 2017;32:474–89.e476.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ku SY, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich ZW, et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science. 2017;355:78–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Spetsieris N, Boukovala M, Patsakis G, Alafis I, Efstathiou E. Neuroendocrine and aggressive-variant prostate cancer. Cancers. 2020;12:3792.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013;19:3621–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rattan SIS, Kyriazis M. The science of hormesis in health and longevity. Elsevier/Academic Press: London, United Kingdom, 2019.

O’Malley J, Kumar R, Inigo J, Yadava N, Chandra D. Mitochondrial stress response and cancer. Trends Cancer. 2020;6:688–701.

Article  PubMed  PubMed Central  Google Scholar 

Fiorese CJ, Schulz AM, Lin YF, Rosin N, Pellegrino MW, Haynes CM. The transcription factor ATF5 mediates a mammalian mitochondrial UPR. Curr Biol. 2016;26:2037–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen CC, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84–88.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cappello F, Conway de Macario E, Marasa L, Zummo G, Macario AJ. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther. 2008;7:801–9.

Article  PubMed  CAS  Google Scholar 

Zhou C, Sun H, Zheng C, Gao J, Fu Q, Hu N, et al. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. Cell Death Dis. 2018;9:161.

Article  PubMed  PubMed Central  Google Scholar 

Kumar R, Chaudhary AK, Woytash J, Inigo JR, Gokhale AA, Bshara W, et al. A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. J Clin Invest. 2022;132:e149906.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bukau B, Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell. 1998;92:351–66.

Article  PubMed  CAS  Google Scholar 

Woytash J, Inigo JR, Chandra D. Assessing oligomerization status of mitochondrial OXPHOS Complexes via blue native page. Methods Mol Biol. 2022;2413:55–62.

Article  PubMed  CAS  Google Scholar 

Gingrich JR, Barrios RJ, Foster BA, Greenberg NM. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis. 1999;2:70–75.

Article  PubMed  CAS  Google Scholar 

Letts JA, Sazanov LA. Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain. Nat Struct Mol Biol. 2017;24:800–8.

Article  PubMed  CAS  Google Scholar 

Wenz T. Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion. 2013;13:134–42.

Article  PubMed  CAS  Google Scholar 

Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, et al. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res. 2014;20:890–903.

Article  PubMed  CAS  Google Scholar 

Ciarlo M, Benelli R, Barbieri O, Minghelli S, Barboro P, Balbi C, et al. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/beta-catenin signaling in prostate cancer cells. Int J Cancer. 2012;131:582–90.

Article  PubMed  CAS  Google Scholar 

Moparthi L, Pizzolato G, Koch S. Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer. Proc Natl Acad Sci USA. 2019;116:22189–95.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Unno K, Chalmers ZR, Pamarthy S, Vatapalli R, Rodriguez Y, Lysy B, et al. Activated ALK cooperates with N-Myc via Wnt/beta-catenin signaling to induce neuroendocrine prostate cancer. Cancer Res. 2021;81:2157–70.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hailesellasse Sene K, Porter CJ, Palidwor G, Perez-Iratxeta C, Muro EM, et al. Gene function in early mouse embryonic stem cell differentiation. BMC Genom. 2007;8:85.

Article  Google Scholar 

Vergara D, Stanca E, Guerra F, Priore P, Gaballo A, Franck J, et al. Beta-catenin knockdown affects mitochondrial biogenesis and lipid metabolism in breast cancer cells. Front Physiol. 2017;8:544.

Article  PubMed  PubMed Central  Google Scholar 

Ma Y, Ma M, Sun J, Li W, Li Y, Guo X, et al. CHIR-99021 regulates mitochondrial remodelling via beta-catenin signalling and miRNA expression during endodermal differentiation. J Cell Sci. 2019;132:jcs229948.

Article  PubMed  CAS  Google Scholar 

Akamatsu S, Inoue T, Ogawa O, Gleave ME. Clinical and molecular features of treatment-related neuroendocrine prostate cancer. Int J Urol. 2018;25:345–51.

Article  PubMed  CAS  Google Scholar 

Flechon A, Pouessel D, Ferlay C, Perol D, Beuzeboc P, Gravis G, et al. Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial. Ann Oncol. 2011;22:2476–81.

Article  PubMed  CAS  Google Scholar 

Waseem M, Bhardwaj M, Tabassum H, Raisuddin S, Parvez S. Cisplatin hepatotoxicity mediated by mitochondrial stress. Drug Chem Toxicol. 2015;38:452–9.

Article  PubMed  CAS  Google Scholar 

Yang Z, Schumaker LM, Egorin MJ, Zuhowski EG, Guo Z, Cullen KJ. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin Cancer Res. 2006;12:5817–25.

Article  PubMed  CAS  Google Scholar 

Podratz JL, Knight AM, Ta LE, Staff NP, Gass JM, Genelin K, et al. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis. 2011;41:661–8.

Article  PubMed